Interpreting Cardiovascular Endpoints in Trials of Antihyperglycemic Drugs
Crossref DOI link: https://doi.org/10.1007/s40256-017-0215-6
Published Online: 2017-02-14
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chawla, Himika
Tandon, Nikhil
License valid from 2017-02-14